Table 2 Associations between oncogenic mutations and clinical characteristics of NPC
From: Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma
Parameter | Mutation group | Wild-type group | P |
|---|---|---|---|
Total | 12 | 58 | Â |
Age (years) | Â | Â | 0.342 |
 >46 | 4 | 31 |  |
 ≤46 | 8 | 27 |  |
Sex | Â | Â | 0.526 |
 Man | 9 | 37 |  |
 Women | 3 | 21 |  |
Clinical stage | Â | Â | 1.00 |
 I + II | 3 | 13 |  |
 III + IV | 9 | 45 |  |
EBV copy number | Â | Â | 0.092 |
 >1,000 | 11 | 38 |  |
 <1,000 | 1 | 20 |  |
Recurrence or metastasis | Â | Â | 0.675 |
 Yes | 1 | 10 |  |
 No | 11 | 48 |  |